Credit Suisse Ag Acadia Pharmaceuticals Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Credit Suisse Ag holds 141,343 shares of ACAD stock, worth $2.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

141,343

Previous 140,422 0.66%

Holding current value

$2.41 Million

Previous $4.4 Million 40.56%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$17.79 - $30.86 $16,384 - $28,422	921 Added 0.66%	141,343 $2.61 Million
Q4 2023 Feb 08, 2024	SELL	$20.78 - $31.77 $185,357 - $283,388	-8,920 Reduced 5.97%	140,422 $4.4 Million
Q3 2023 Nov 13, 2023	SELL	$20.84 - $33.47 $527,710 - $847,527	-25,322 Reduced 14.5%	149,342 $3.11 Million
Q2 2023 Aug 11, 2023	SELL	$17.8 - $25.65 $536,634 - $773,296	-30,148 Reduced 14.72%	174,664 $4.18 Million
Q1 2023 May 10, 2023	BUY	$16.32 - $20.92 $67,434 - $86,441	4,132 Added 2.06%	204,812 $3.85 Million
Q4 2022 Feb 13, 2023	BUY	$14.2 - $18.63 $328,176 - $430,557	23,111 Added 13.02%	200,680 $3.19 Million
Q3 2022 Nov 10, 2022	SELL	$14.11 - $18.27 $157,580 - $204,039	-11,168 Reduced 5.92%	177,569 $2.91 Million
Q2 2022 Aug 12, 2022	BUY	$13.01 - $27.22 $236,456 - $494,723	18,175 Added 10.66%	188,737 $2.66 Million
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $127,713 - $167,722	-6,099 Reduced 3.45%	170,562 $4.13 Million
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $1.09 Million - $1.76 Million	-64,933 Reduced 26.88%	176,661 $4.12 Million
Q3 2021 Nov 12, 2021	BUY	$15.78 - $24.77 $1.8 Million - $2.83 Million	114,340 Added 89.85%	241,594 $4.01 Million
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $375,894 - $531,289	-19,376 Reduced 13.21%	127,254 $3.1 Million
Q1 2021 May 14, 2021	SELL	$25.02 - $54.99 $37,254 - $81,880	-1,489 Reduced 1.01%	146,630 $3.78 Million
Q4 2020 Feb 12, 2021	BUY	$41.04 - $56.79 $332,054 - $459,487	8,091 Added 5.78%	148,119 $7.92 Million
Q3 2020 Nov 13, 2020	SELL	$36.42 - $57.0 $5.79 Million - $9.06 Million	-159,025 Reduced 53.18%	140,028 $5.78 Million
Q2 2020 Aug 12, 2020	BUY	$39.26 - $52.73 $7.61 Million - $10.2 Million	193,958 Added 184.55%	299,053 $14.5 Million
Q1 2020 May 13, 2020	SELL	$31.65 - $46.87 $2.77 Million - $4.1 Million	-87,411 Reduced 45.41%	105,095 $4.44 Million
Q4 2019 Feb 12, 2020	SELL	$36.21 - $51.4 $1.36 Million - $1.92 Million	-37,437 Reduced 16.28%	192,506 $8.23 Million
Q3 2019 Nov 12, 2019	BUY	$22.22 - $44.01 $2.67 Million - $5.3 Million	120,375 Added 109.86%	229,943 $8.28 Million
Q2 2019 Aug 14, 2019	BUY	$23.32 - $28.12 $464,954 - $560,656	19,938 Added 22.24%	109,568 $2.93 Million
Q1 2019 May 14, 2019	SELL	$16.17 - $27.38 $36,156 - $61,221	-2,236 Reduced 2.43%	89,630 $2.41 Million
Q4 2018 Feb 13, 2019	BUY	$14.32 - $22.92 $238,671 - $382,007	16,667 Added 22.16%	91,866 $1.49 Million
Q3 2018 Nov 13, 2018	SELL	$13.03 - $21.81 $338,727 - $566,972	-25,996 Reduced 25.69%	75,199 $1.56 Million
Q2 2018 Aug 14, 2018	BUY	$15.07 - $22.34 $300,043 - $444,789	19,910 Added 24.49%	101,195 $1.55 Million
Q1 2018 May 15, 2018	SELL	$22.47 - $32.33 $49,434 - $71,126	-2,200 Reduced 2.64%	81,285 $1.83 Million
Q4 2017 Feb 14, 2018	SELL	$26.84 - $39.14 $3.8 Million - $5.54 Million	-141,500 Reduced 62.89%	83,485 $2.52 Million
Q3 2017 Nov 14, 2017	SELL	$29.49 - $38.37 $1.25 Million - $1.63 Million	-42,395 Reduced 15.86%	224,985 $8.47 Million
Q2 2017 Aug 14, 2017	BUY	N/A	267,380	267,380 $7.46 Million

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account